Geoffrey von Maltzahn
Founder chez Resonance Therapeutics
Profil
Geoffrey von Maltzahn founded Seres Therapeutics, Inc. in 2010, where he worked as Chief Technology Officer from 2010 to 2012, Axcella Health, Inc. in 2008, where he worked as Vice President-Discovery from 2008 to 2013, Indigo Ag, Inc. in 2013, where he is working as Chief Innovation Officer & Director, Kaleido Biosciences, Inc. in 2015, where he worked as Director from 2017 to 2022, Generate Biomedicines, Inc. in 2018, where he is working as Director from 2018, and Quotient Therapeutics Ltd.
in 2022, where he is working as Chief Executive Officer from 2022.
Dr. von Maltzahn also founded Resonance Therapeutics and Sienna Biopharmaceuticals, Inc. Dr. von Maltzahn also currently works at Tessera Therapeutics, Inc., as Director and Flagship Pioneering, as General Partner.
Dr. von Maltzahn also formerly worked at Cobalt Biomedicine, Inc., as President, Chief Executive Officer & Director, Sana Biotechnology, Inc., as Independent Director from 2019 to 2021, and Essentient, Inc., as Vice President-Corporate Development.
Dr. von Maltzahn received his undergraduate degree and doctorate degree from Massachusetts Institute of Technology and graduate degree from the University of California San Diego.
Postes actifs de Geoffrey von Maltzahn
| Sociétés | Poste | Début |
|---|---|---|
Resonance Therapeutics
 Resonance Therapeutics Medical/Nursing ServicesHealth Services Resonance Therapeutics develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics. The company is headquartered in Boston, MA. | Founder | 17/09/2009 |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Founder | 01/01/2013 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2009 |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Founder | 01/01/2018 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de Geoffrey von Maltzahn
| Sociétés | Poste | Fin |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Founder | 15/03/2022 |
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 01/09/2021 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Chief Executive Officer | 01/02/2019 |
Essentient, Inc.
 Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Essentient, Inc. develops transforming global nutrition. The company involves in research and development in biotechnology. The company was founded in 2008 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 17/02/2014 |
| ░░░░ ░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Formation de Geoffrey von Maltzahn
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California San Diego | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Resonance Therapeutics develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics. The company is headquartered in Boston, MA. | Health Services |
Essentient, Inc.
Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Essentient, Inc. develops transforming global nutrition. The company involves in research and development in biotechnology. The company was founded in 2008 and is headquartered in Cambridge, MA. | Commercial Services |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |
